24 participants
Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-04-12
- Start Date:
- 2016-01-08
- Completion:
- 2020-03-05
Conditions
- Primary Peritoneal Carcinoma
Interventions
- DRUG
No Results Yet